BACKGROUND: Patient-provider sexual risk behavior discussions occur infrequently but may be facilitated by high-quality sexual risk screening tools. OBJECTIVE: To develop the Sexual Risk Behavior Inventory (SRBI), a brief computer-administered patient-reported measure. DESIGN: Qualitative item development/quantitative instrument validation. PARTICIPANTS: We developed SRBI items based on patient interviews (n = 128) at four geographically diverse US primary care clinics. Patients were diverse in gender identity, sex, sexual orientation, age, race/ethnicity, and HIV status. We compared sexual risk behavior identified by the SRBI and the Risk Assessment Battery (RAB) among patients (n = 422). APPROACH: We constructed an item pool based on validated measures of sexual risk, developed an in-depth interview guide based on pool content, and used interviews to elicit new sexual risk concepts. We coded concepts, matched them to item pool content, and developed new content where needed. A provider team evaluated item clinical relevance. We conducted cognitive interviews to assess item comprehensibility. We administered the SRBI and the RAB to patients. KEY RESULTS: Common, clinically relevant concepts in the SRBI included number of sex partners; partner HIV status; partner use of antiretroviral medication (ART)/pre-exposure prophylaxis (PrEP); and recent sex without barrier protection, direction of anal sex, and concern regarding HIV/STI exposure. While 90% reported inconsistent condom use on the RAB, same-day SRBI administration revealed that for over one third, all their partners were on ART/PrEP. CONCLUSION: The SRBI is a brief, skip-patterned, clinically relevant measure that ascertains sexual risk behavior across sex, sexual orientation, gender identity, partner HIV serostatus, and partner treatment status, furnishing providers with context to determine gradations of risk for HIV/STI.
BACKGROUND:Patient-provider sexual risk behavior discussions occur infrequently but may be facilitated by high-quality sexual risk screening tools. OBJECTIVE: To develop the Sexual Risk Behavior Inventory (SRBI), a brief computer-administered patient-reported measure. DESIGN: Qualitative item development/quantitative instrument validation. PARTICIPANTS: We developed SRBI items based on patient interviews (n = 128) at four geographically diverse US primary care clinics. Patients were diverse in gender identity, sex, sexual orientation, age, race/ethnicity, and HIV status. We compared sexual risk behavior identified by the SRBI and the Risk Assessment Battery (RAB) among patients (n = 422). APPROACH: We constructed an item pool based on validated measures of sexual risk, developed an in-depth interview guide based on pool content, and used interviews to elicit new sexual risk concepts. We coded concepts, matched them to item pool content, and developed new content where needed. A provider team evaluated item clinical relevance. We conducted cognitive interviews to assess item comprehensibility. We administered the SRBI and the RAB to patients. KEY RESULTS: Common, clinically relevant concepts in the SRBI included number of sex partners; partner HIV status; partner use of antiretroviral medication (ART)/pre-exposure prophylaxis (PrEP); and recent sex without barrier protection, direction of anal sex, and concern regarding HIV/STI exposure. While 90% reported inconsistent condom use on the RAB, same-day SRBI administration revealed that for over one third, all their partners were on ART/PrEP. CONCLUSION: The SRBI is a brief, skip-patterned, clinically relevant measure that ascertains sexual risk behavior across sex, sexual orientation, gender identity, partner HIV serostatus, and partner treatment status, furnishing providers with context to determine gradations of risk for HIV/STI.
Entities:
Keywords:
patient-reported outcomes; sexual risk behavior measurement
Authors: M Barton Laws; Ylisabyth S Bradshaw; Steven A Safren; Mary Catherine Beach; Yoojin Lee; William Rogers; Ira B Wilson Journal: AIDS Behav Date: 2011-05
Authors: S D Rosenberg; S L Trumbetta; K T Mueser; L A Goodman; F C Osher; R M Vidaver; D S Metzger Journal: Compr Psychiatry Date: 2001 Jul-Aug Impact factor: 3.735
Authors: Jonathan A Glaude-Hosch; Matthew Lee Smith; Timothy G Heckman; Toni P Miles; Babatunde A Olubajo; Marcia G Ory Journal: Curr HIV Res Date: 2015 Impact factor: 1.581
Authors: Angela Stover; Debra E Irwin; Ronald C Chen; Bhishamjit S Chera; Deborah K Mayer; Hyman B Muss; Donald L Rosenstein; Thomas C Shea; William A Wood; Jessica C Lyons; Bryce B Reeve Journal: EGEMS (Wash DC) Date: 2015-10-29
Authors: Cornelis A Rietmeijer; Patricia J Kissinger; Vincent Guilamo-Ramos; Charlotte A Gaydos; Edward W Hook; Aimee Mead; Sophie Yang; Amy Geller; Sten H Vermund Journal: Sex Transm Dis Date: 2022-02-01 Impact factor: 3.868
Authors: R J Fredericksen; L E Gibbons; E Fitzsimmons; R M Nance; K R Schafer; D S Batey; S Loo; S Dougherty; W C Mathews; K Christopoulos; K H Mayer; M J Mugavero; M M Kitahata; P K Crane; H M Crane Journal: AIDS Care Date: 2021-01-14